Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer
Clinical trial NCT04619069 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04619069
- Sponsor
- Sunnybrook Health Sciences Centre
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-27
- Primary completion
- 2030-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.